Great to see the collaboration ...
Unfortunately the market doesn’t seem too excited about it at the moment
That’s okay, personally I see this as a giant step forward
Why ...
The Company is incorporating these insights and using its access to Garvan’s clinical research network to assist with the design and planning of a Phase 2 clinical trial of AMP945 in patients with pancreatic cancer that is scheduled to commence later this year.
Rome wasn’t built in a day, these guys are on the road to a great success story
Im just pleased I can be part of this journey ...
.
Ann: Annual General Meeting to be Held 27 August 2021, page-8
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.012(12.0%) |
Mkt cap ! $24.13M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 8.6¢ | $614.5K | 5.826M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122997 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 11000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| ATX (ASX) Chart |